Ropes & Gray Logo
Page Translations
Bob Rivollier

Bob A. Rivollier

Partner
Languages: French, German, Luxembourgish
Areas of Practice
  • *
Jump to:

Bob Rivollier is a partner in the private equity transactions group in the firm’s New York office. With over a decade of experience advising clients on leveraged buyouts, M&A and financing transactions, Bob is a trusted adviser for private equity sponsors and their portfolio companies on their most critical transactions and other business initiatives.

Bob has advised clients on many large transactions, including complex carve-out transactions, across many industries and verticals, such as health care and pharma, industrials, technology, business services, and consumer/retail. Within the health care industry, Bob has also developed a particular focus on management services organizations. 

Some recent examples of Bob’s work include:

  • Health care and pharma: advising Avista Healthcare Partners on its acquisition of Probo Medical, Avista’s portfolio company United BioSource on its acquisitions of Marketshare Movers and Examoto, and TPG’s portfolio company BVI® on its acquisition of Benz Research & Development
  • Industrials: advising American Industrial Partners on the sale of AHF Products and The Cabinetworks Group, and the acquisition of the Lewisport automotive body sheet plant from Novelis
  • Technology: assisting Partners Group on its minority investment in VelocityEHS and its majority investment in Idera, and Wirecard on the sale of its U.S. business to Syncapay
  • Business services: advising Partners Group on the acquisition of Foundation Risk Partners and the sale of a 50% stake in USIC to a consortium led by Kohlberg & Company
  • Consumer/Retail: guiding Partners Group on its acquisition of Careismatic Brands
  • Management services organizations: representing Avista Healthcare Partners on its acquisition of National Spine and Pain Centers, Heartland Dental on its acquisition by KKR, and Heartland Dental on its acquisition of American Dental Partners 

A native of Luxembourg, educated in Belgium, Scotland and the United States, and fluent in English, French, German and Luxembourgish, Bob brings a valuable global perspective to a dealmaking landscape that is increasingly cross-border in nature. He has worked as a transactional lawyer in both New York and London, and he frequently represents non-U.S. private equity sponsors in connection with their inbound investments into the United States. 

Ranked Up & Coming in Chambers USA 2020-2022 and Chambers Global 2021-2022, Bob has been described by clients as “a sharp negotiator”, “very thoughtful” and “commercially savvy.” Clients say that they “truly value his guidance in tough situations” and that Bob is someone they can trust in complex transactions.

Experience

  • Represented American Industrial Partners on
    • its acquisition of PPG’s architectural coatings business
    • its majority investment in Austin Powder, a leading provider of industrial explosives and engineered blasting solutions
    • its acquisition of Veolia North America’s sulfuric acid regeneration business
    • the sale of Virtek Vision International to AMETEK (October 2024)
    • the sale of Collins Bus Corporation by its portfolio company, REV Group (January 2024)
    • the sale of AHF Products to Paceline Equity Partners (September 2022)
    • the sale of The Cabinetworks Group to Platinum Equity (May 2021)
    • the sale of Gerber Technology to Lectra S.A. for an enterprise value of about 300 million euros (May 2021)
    • the acquisition of the Lewisport automotive body sheet plant from Novelis in a DOJ-mandated process (December 2020)
    • the sale of its shuttle bus businesses by its portfolio company, REV Group (May 2020)
    • the $1bln acquisition of Masco Corporation’s kitchen and bath cabinetry business by its portfolio company, acpi® (February 2020)
    • the sale of a partial ownership stake in Shape Technologies Group to DCP Capital (June 2019)
    • the acquisition of Elkay Wood Products Company by its portfolio company, acpi® (February 2019)
    • the acquisition of Metso Corporation’s grinding media business by its portfolio company, Moly-Cop (December 2018)
    • its acquisition of CQMS Razer™ (August 2018)
    • the acquisition of the steel fabrication business of Commercial Metals Company by its portfolio company, FabSouth (April 2018)
    • the acquisition of Ferrara Fire Apparatus by its portfolio company, REV Group (April 2017)
  • Represented Aquiline Capital Partners on its acquisition of Aspirion Health Resources (May 2018), and Aspirion on its acquisition of HRS ERASE (December 2018) and Specialized Healthcare Partners (July 2019)
  • Represented Atairos on its acquisition of an ownership position in ProQuest (June 2019)
  • Represented Avista Healthcare Partners on
    • its investment in Global Contract Manufacturing (GCM), an outsourced manufacturer of high-precision components and assemblies
    • the acquisition of Taconic Biosciences, a provider of genetically engineered research models and related services (November 2022)
    • the acquisition of Probo Medical (March 2022)
    • the sale of Arcadia Consumer Healthcare to Bansk Group (September 2021)
    • its investment in eMolecules (April 2021), and eMolecules on its acquisition of Frontier Scientific and Frontier Agricultural Sciences (September 2022)
    • the acquisition of NATURELO® by its portfolio company, Arcadia Consumer Healthcare (October 2020)
    • the purchase of the U.S. rights to the Kaopectate® brand from Sanofi by its portfolio company, Arcadia Consumer Healthcare (March 2020)
    • the acquisition of Xifin, Inc. (February 2020)
    • the acquisition of GCM Holding Corporation (August 2019)
    • the sale of Zest Dental Solutions (March 2018)
    • a Series B investment in Braeburn Pharmaceuticals (January 2018)
    • the acquisition of United BioSource, a wholly-owned subsidiary of Express Scripts Holding Company (December 2017), and UnitedBioSource on its acquisitions of Marketshare Movers (March 2022) and Examoto (August 2022)
    • the acquisition of National Spine and Pain Centers (June 2017), and NSPC on its affiliations with Advanced Medical Group, PA (January 2018), Specialty Spine and Pain, P.C. (March 2019), Millennium Pain Center, LLC (June 2019), and Pain Management Consultants of Southwest Florida, P.L. (February 2020)
    • the acquisition of a majority stake in Vertical Pharmaceuticals and Trigen Laboratories (December 2013)*; the combination of Vertical Pharmaceuticals and Trigen Laboratories with Osmotica Pharmaceuticals (February 2016)*; and the initial public offering of Osmotica Pharmaceuticals (November 2018)
  • Represented Avista Healthcare Partners and Partners Group on their acquisition of Strategic Partners (August 2012)*
  • Represented Partners Group and Charlesbank Capital Partners on their acquisition of Hearthside Food Solutions (May 2018), and Hearthside Food Solutions on its $1.1bln acquisition of Greencore USA (November 2018), on its acquisition of the bakery business of Weston Foods (December 2021) and on its sale of its European business (October 2023)
  • Represented Partners Group on its
    • sale of a 50% stake in USIC to a consortium led by Kohlberg & Company (November 2022)
    • acquisition of Foundation Risk Partners (September 2022)
    • significant minority investment in VelocityEHS (September 2022)
    • follow-on investment into PCI Pharma Services in connection with PCI’s acquisition of Lyophilization Services of New England (December 2021)
    • follow-on investment into Allied Universal in connection with Allied Universal’s acquisition of G4S plc (April 2021)
    • majority investment in Idera, Inc. (March 2021)
    • acquisition of Careismatic Brands (January 2021)
    • minority investment in Idera, Inc. (June 2019)
    • acquisition of United States Infrastructure Corporation (November 2017), and USIC on its acquisition of On Target Utility Services (June 2018)
    • acquisition of Universal Services of America (July 2013)*; the sale of Universal Services of America (Universal) to an affiliate of Warburg Pincus, and on its minority investment alongside Warburg Pincus into the combined Universal/Guardsmark business (July 2015)*
    • its investment in Gateway Fleets, a provider of electrification services for logistics fleet operators in the United States
    • its acquisition of Foundation Risk Partners
    • acquisition of Universal Services of America*; the sale of Universal to an affiliate of Warburg Pincus, and on its minority investment alongside Warburg Pincus into the combined Universal/Guardsmark business
  • Represented TPG on the acquisition of Benz Research & Development by its portfolio company, BVI® (September 2020)
  • Represented Heartland Dental on
    • its acquisition of American Dental Partners (June 2021)
    • the acquisition of a majority interest in Heartland Dental by KKR (April 2018)
  • Represented Castanea Partners on its acquisition of Yasso (March 2017)
  • Represented Wirecard Acquiring & Issuing GmbH, a 100% subsidiary of Wirecard AG, on the sale of North Lane Technologies (f/k/a Wirecard North America) to Syncapay, Inc. (December 2020)
  • Represented Flexis Capital and TZP Group on their acquisition of Hylan Datacom & Electrical (July 2016)*
  • Represented Perella Weinberg Partners on its significant Investment in Hyphen Solutions (May 2016)*
  • Represented The Jordan Company on its acquisition of Capstone Logistics (August 2014)*, and Capstone Logistics on its acquisition of Pinnacle Workforce Logistics (June 2015)* and Best Loading Service (April 2016)*
  • Tele2 AB, a Swedish public company, on the sale of Tele2 Luxembourg and Tele2’s fixed and mobile operations in Liechtenstein to Belgium-based Belgacom for approximately $330 million (June 2008)*

Please note that representations with an asterisk (*) were completed prior to joining Ropes & Gray LLP

Areas of Practice